Trial Profile
Comparison Sugammadex With Neostigmine in Laryngeal Microsurgery.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Apr 2017
Price :
$35
*
At a glance
- Drugs Neostigmine (Primary) ; Sugammadex (Primary) ; Rocuronium bromide
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- 06 Sep 2016 Status changed from recruiting to completed.
- 24 Nov 2015 Planned primary completion date changed from 1 May 2015 to 1 May 2016 as reported by ClinicalTrials.gov record.
- 05 Jan 2015 New trial record